Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2005
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1661482A Polymeric charge transport compositions for organophotoreceptors
08/31/2005CN1660842A Preparation of 4-hydroxy-3-nitro-2(1h)-pyridone from 2-hydroxy-3-cyano-4-methoxypyridine
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1216883C Synthesis of anticancer medicine raltiprexed
08/30/2005US6936721 good electronic delocation of electrons pi; high complexing properties; high thermal stability; optical limiter properties
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077937A1 Substituted hydroxamic acid derivatives as tnf inhibitors
08/25/2005WO2005077932A2 Chemokine receptor antagonists
08/25/2005WO2005077922A2 Process for the preparation of substituted triazole compounds
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077897A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005WO2005077344A2 Hydantoin derivatives as inhibitors of cellular necrosis
08/25/2005WO2005023818A3 Heterobicyclic compounds as pharmaceutically active agents
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050187238 Benzofuran derivatives, their production and use
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187208 Substituted Azetidine compounds, their preparation and use as medicaments
08/25/2005US20050187110 Novel herbicides
08/25/2005CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005CA2555825A1 Process for the preparation of substituted triazole compounds
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2536622A1 Inhibitors of cellular necrosis
08/24/2005EP1565460A1 Method for preparing oltipraz
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1565458A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565450A1 Tetrahydropyran derivatives
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1565187A2 Methods of treating cancer and related methods
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1072266B1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659155A 1-phenylalkyl-piperazines
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658871A Amide derivatives as GK activators
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/23/2005CA2138288C Substituted azabicycloheptane derivatives, their preparation and use
08/18/2005WO2005075978A2 Time-temperature indicator based on valence isomerizations
08/18/2005WO2005075466A1 Substituted thienyl-mercaptoketones, and use thereof for treating diseases associated with histone deacetylase enzymatic activity
08/18/2005WO2005075465A1 Benzimidazol substituted thiopene derivatives with atctivity on ikk3
08/18/2005WO2005075464A1 Pyridine derivatives as connabinoid receptor modulators
08/18/2005WO2005075463A1 Benzopyran derivatives, method of production and use thereof
08/18/2005WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists
08/18/2005WO2005075451A1 Aminodibenzodioxin derivative and organic electroluminescent device using same
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators
08/18/2005WO2005075425A2 Substituted bisarylurea derivatives as kinase inhibitors
08/18/2005WO2005074933A1 Small molecule inhibitors of her2 expression
08/18/2005WO2005074642A2 Chemical compounds
08/18/2005WO2005034172A3 Material and cell structure for memory applications
08/18/2005US20050182121 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use
08/18/2005US20050182116 Such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/18/2005US20050182101 Prodrugs of proton pump inhibitors
08/18/2005US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 523